Michael L Cheng

12PUBLICATIONS
111CO-AUTHORS
Molecular targetsHaematological tumoursCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 07, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Alison M Schram, Abdul Rafeh Naqash, Eric B Haura

|Oct 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.

Gregory M Cote, Bose S Kochupurakkal, Khanh Do

|Jan 26, 2024
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer.

Hewitt Chang, Jaqueline Marquez, Brandon K Chen

|Apr 25, 2023
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.

Biagio Ricciuti, Arielle Elkrief, Joao Alessi

Pageof 2